KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Share-based Compensation (2016 - 2026)

Supernus Pharmaceuticals has reported Share-based Compensation over the past 15 years, most recently at $9.7 million for Q4 2025.

  • Quarterly Share-based Compensation rose 26.45% to $9.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.1 million through Dec 2025, up 19.08% year-over-year, with the annual reading at $33.1 million for FY2025, 19.08% up from the prior year.
  • Share-based Compensation was $9.7 million for Q4 2025 at Supernus Pharmaceuticals, up from $7.8 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $9.7 million in Q4 2025 and troughed at $4.0 million in Q1 2022.
  • The 5-year median for Share-based Compensation is $6.2 million (2023), against an average of $6.2 million.
  • Year-over-year, Share-based Compensation dropped 21.53% in 2022 and then surged 58.88% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $4.0 million in 2021, then grew by 5.57% to $4.3 million in 2022, then skyrocketed by 51.26% to $6.4 million in 2023, then grew by 18.42% to $7.6 million in 2024, then increased by 26.45% to $9.7 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Share-based Compensation are $9.7 million (Q4 2025), $7.8 million (Q3 2025), and $7.5 million (Q2 2025).